|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3097119 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15703187.3 |
| Date of filing the European patent application | 2015-01-23 | |
| (97) | Date of publication of the European application | 2016-11-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation | 2021-10-11 |
| (86) | Number | PCT/US2015/012589 |
| Date | 2015-01-23 |
| (87) | Number | WO 2015/112800 |
| Date | 2015-07-30 |
| (30) | Number | Date | Country code |
| 201461930576 P | 2014-01-23 | US | |
| 201462014181 P | 2014-06-19 | US |
| (72) |
PAPADOPOULOS, Nicholas, J. , US
MURPHY, Andrew, J. , US
THURSTON, Gavin , US
IOFFE, Ella , US
BUROVA, Elena , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Žmogaus antikūnai prieš PD-1 |
| HUMAN ANTIBODIES TO PD-1 |
| Payment date | Validity (years) | Amount | |
| 2024-12-18 | 11 | 289.00 EUR |
| 2026-01-23 |